Congenital dyserythropoietic anemia type II: Epidemiology, clinical appearance, and prognosis based on long-term observation

Blood

Volumn 102, Issue 13, 2003, Pages 4576-4581

  Heimpel, Hermann ^a   Anselstetter, Volker ^b   Chrobak, Ladislav ^b   Denecke, Jonas ^b   Einsiedler, Beate ^b   Gallmeier, Kerstin ^b   Griesshammer, Antje ^b   Marquardt, Thorsten ^b   Janka Schaub, Gritta ^b   Kron, Martina ^b   Kohne, Elisabeth ^b  

^a UNIVERSITY OF ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLECYSTECTOMY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 2; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; FEMALE; GALLSTONE; HEMOCHROMATOSIS; HEMOGLOBIN DETERMINATION; HEREDITARY HEMOLYTIC ANEMIA; HEREDITY; HUMAN; IRON DEPLETION; IRON OVERLOAD; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RETICULOCYTE COUNT; SPLENECTOMY; THALASSEMIA; TREATMENT INDICATION;

EID: 10744220216     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-02-0613     Document Type: Article

References (54)

1. Crookston JH, Godwin TF, Wightmann KJR, Dacie JV, Lewis SM, Patterson M. Congenital dyserythropoietic anemia. Abstr XIth Congress Int Soc Hematol, Sydney, Australia. 1966.
2. Wendt F, Heimpel H. Kongenitale dyserythropoetische Anämie bei einem eineiigen Zwillingspaar. Med Klinik. 1967;62:172-177.
3. Heimpel H, Wendt F. Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta. 1968;34;103-115.
4. Wickramasinghe SN. Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data. Blood Rev. 1998;12:178-200.
5. Delaunay J, Iolascon A. The congenital dyserythropoietic anaemias. Baillieres Best Pract Res Clin Haematol. 1999;12:691-705.
6. Crookston JH, Crookston MC, Burnie KL, et al. Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: a type of congenital dyserythropoietic anemia. Br J Haematol. 1969;17:11-26.
7. Iolascon A, D'Agostaro G, Perrotta S, Izzo P, Tavano R, Miraglia del Giudice B. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects. Haematologica. 1996;81:543-559.
8. Heimpel H, Maier K. Congenital dyserythropoietic anemia: a first approach to epidemiology [abstract]. Haematologica. 1999;84(EHA-abstracts): 194.
9. Queisser W, Spiertz E, Jost E, Heimpel H. Proliferation disturbances of erythroblasts in congenital dyserythropoietic anemia type I and II. Acta Haematol. 1971;45:65-76.
10. Heimpel H, Forteza-Vila J, Queisser W. Morphological aberrations of the erythroblasts in congenital dyserythropoietic anemia type I and II [abstract]. Abstr Vol XIII Int Congr Int Soc Hematol. Munich 1970. 1970;371.
11. Alloisio N, Texier P, Denoroy L, et al. The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum. Blood. 1996;87:4433-4439.
12. Anselstetter V, Horstmann K, Heimpel H. Congenital dyserythropoetic anaemia, types I and II: aberrant pattern of erythrocyte membrane proteins in CDA II, as revealed by two-dimensional polyacrylamide gel electrophoresis. Br J Haematol. 1977;35:209-215.
13. Fukuda MN, Papayannopoulou T, Gordon-Smith EC, Rochant H, Testa U. Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS). Br J Haematol. 1984;56:55-68.
14. Zdebska E, Anselstetter V, Pacuszka T, et al. Glycolipids and glycopeptides of red cell membranes in congenital dyserthropoetic anemia type II (CDA II). Br J Haematol. 1987;66:385-391.
15. Iolascon A, Miraglia del Giudice E, Perrotta S, Granatiero M, Zelante L, Gasparini P. Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II). Blood. 1997;90:4197-4200.
16. Heimpel H, Wendt F, Klemm D, Schubothe H, Heilmeyer L. Kongenitale dyserythropoietische Anämie, Dtsch Arch Klin Med. 1968;215:174-194.
17. Minssen M, Klaus D. Familiäre Vielkernigkeit der Erythroblasten mit makrozytärer Anämie durch ineffektive Erythropoese und gesteigerte Hämolyse. Med Welt. 1968;19:2280-2283.
18. Hartwich G, Wolf F, Becker J, Keilhack W, Schwanitz G. Kongenitale dyserythropoietische Anämie. Blut. 1971;23:347-358.
19. Schatanek W, Hufnagl HD, Meiser RJ, Berberich R. Kongenitale dyserythropoetische Anämie mit Eisenspeicherkrankheit. Muench Med Wochenschr. 1972;114:1933-1936.
20. Kurz R, Huber C, Reinken L, Huber H. Kongenitale dyserythropoetische Anämie II: Pädiatrie und Pädologie. 1973;8:135-146.
21. Hartwich G, Riemann J, Kronert E. Kongenitale dyserythropoietische Anemia Typ II: ein weiterer Fallbericht. Med Klinik. 1976;71:2117-2122.
22. Chrobak L, Radochova D, Smetana K. Congenital dyserythropoietic anaemia type II (HEMPAS) in three siblings. Folia Haematol (Leipz). 1980;107:628-640.
23. Koehler M, Schmidt-Riese L, Brandeis WE. Morphological studies of erythrocytes in congenital dyserythropoietic anemia type II [in Polish]. Acta Haematol Pol. 1990;21:144-152.
24. Hofmann WK, Kaltwasser JP, Hoelzer D, Nielsen P, Gabbe EE. Successful treatment of iron overload by phlebotomies in a patient with severe congenital dyserythropoietic anemia type II [letter]. Blood. 1997;89:3068-3069.
25. Denecke J, Kranz C, Conradt H, Heimpel H, Weglage J, Marquardt T. Congenital dyserythropoietic anemia typ II (CDAII/Hempas), new biochemical insight in a disorder or glycosylation [abstract]. J Inherit Metabol Dis. 2001;111.
26. International Committee for Standardisation in Hematology. Recommended methods for radioisotope red-cell survival studies. Br J Haematol. 1980;45:659-666.
27. Crookston JH, Crookston MC, Rosse WF. Red-cell abnormalities in HEMPAS (hereditary erythroblastic mulitnuclearity with a positive acidified-serum test). Br J Haematol. 1972;23(suppl): 83-91.
28. Erdmann H, Heimpel H, Buchta H. Positiver Säureserumtest und erhöhte Agglutinabilität durch Anti-i bei Patienten mit kongenitaler dyserythropoietischer Anämie. Klin Wochenschr. 1970;48:569-570.
29. Heimpel H, Forteza-Vila J, Queisser W, Spiertz E. Electron and light microscopic study of the erythropoiesis of patients with congenital dyserythropoietic anemia. Blood. 1971;37:299-310.
30. Wonke B. Clinical management of beta-thalassemia major. Semin Hematol. 2001;38:350-359.
31. Fukuda MN. HEMPAS disease: genetic defect of glycosylation. Glycobiology. 1990;1:9-15.
32. McBride JA, Wilson WE, Baillie N. Congenital dyserythropoietic anaemia: type IV [abstract]. Blood. 1971;38:837. Abstract 153.
33. Seip M, Skrede S, Bjerve K, et al. A case of variant congenital dyserythropoietic anemia revisited. Scand J Haematol. 1982;28:278-280.
34. Benjamin JT, Rosse WF, Dalldorf FG, McMillan CW. Congenital dyserythropoetic anemia: type IV. J Pediatr. 1975;87:210-216.
35. Eldor A, Matzner Y, Kahane I, Levene C, Polliack A. Aberrant congenital dyserythropoietic anemia with negative acidified serum tests and features of thalassemia in a Kurdish family. Isr J Med Sci. 1978;14:1138-1143.
36. Iolascon A, Delaunay J, Wickramasinghe SN, Perrotta S, Gigante M, Camaschella C. Natural history of congenital dyserythropoietic anemia type II. Blood. 2001;98:1258-1260.
37. Iolascon A, Servedio V, Carbone R, et al. Geographic distribution of CDA-II: did a founder effect operate in Southern Italy? Haematologica. 2000;85:470-474.
38. Iolascon A, De Mattia D, Perrotta S, et al. Genetic heterogeneity of congenital dyserythropoietic anemia type II [letter]. Blood. 1998;92:2593-2594.
39. Greiner TC, Burns CP, Dick FR, Henry KM, Mahmood I. Congenital dyserythropoietic anemia type II diagnosed in a 69-year-old patient with iron overload. Am J Clin Pathol. 1992;98:522-525.
40. Iolascon A, Sabato V, De Mattia D, Locatelli F. Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II). Bone Marrow Transplant. 2001;27:213-215.
41. Perrotta S, del Giudice EM, Carbone R, et al. Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II). J Pediatr. 2000;136:556-559.
42. Gasparini P, Miraglia del Giudice E, Delaunay J, et al. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. Am J Hum Genet. 1997;61:1112-1116.
43. Shalev H, Kapleushnik Y, Haeskelzon L, et al. Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in young adults. Eur J Haematol. 2002;68:170-174.
44. Van Steenbergen W, Matthijs G, Roskams T, Fevery J. Noniatrogenic haemochromatosis in congenital dyserythropoietic anaemia type II is not related to C282Y and H63D mutations in the HFE gene: report on two brothers. Acta Clin Belg. 2002;57:79-84.
45. Cazzola M, Barosi G, Bergamaschi G, et al. Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol. 1983;54:649-654.
46. Franchini M, Gandini G, Girelli D, Lippi G, de Gironcoli M, Aprili G. Association of phlebotomy and subcutaneous bolus injection of deferoxamine for the treatment of anemic patients with iron overload. Haematologica 2001;86:873-874.
47. Chrobak L, Spacek J. Favorable effect of splenectomy on anemia in 3 siblings with type II congenital dyserythropoietic anemia (HEMPAS) (ultrastructural changes in erythrocytes after splenectomy) [in Czech]. Vnitr Lek. 1997;43:635-638.
48. Barosi G, Cazzola M, Stefanelli M, Ascari E. Studies of ineffective erythropoiesis and peripheral haemolysis in congenital dyserythropoietic anaemia type II. Br J Haematol. 1979;43:243-250.
49. Heimpel H, Eggl C, Griesshammer A, Maier K, Kohne E. Splenectomy in congenital dyserythropoietic anemia [abstract]. Egypt J Haematol. 2002;27:83-84.
50. Bethlentalvay NC, Hadnagy GS, Heimpel H. Unclassified type of congenital dyserythropoietic anemia (CDA) with prominent peripheral erythoblastosis. Br J Haematol. 1985;60:541-550.
51. Bird AR, Karabus CD, Hartley PS. Unclassified type of congenital dyserythropoietic anemia (CDA) with prominent erythroblastosis. Br J Haematol. 1986;63:797-798.
52. Adams CD, Kessler JF. Circulating nucleated red blood cells following splenectomy in a patient with congenital dyserythropoietic anemia. Am J Hematol. 1991;38:120-123.
53. Fischer R, Tiemann CD, Engelhardt R, et al. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol. 1999;60:289-299.
54. Marchetti M, Quaglini S, Barosi G. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios. J Intern Med. 1998;244:217-226.